SCM
THC icon

Sirios Capital Management’s Tenet Healthcare THC Stock Holding History

Sirios Capital Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07M Sell
21,739
-15,905
-42% -$2.92M 0.49% 47
2026
Q1 		$7.1M Sell
37,644
-11,407
-23% -$2.4M 0.86% 38
2025
Q4 		$9.75M Sell
49,051
-22,515
-31% -$4.55M 1.21% 30
2025
Q3 		$14.5M Buy
71,566
+35,947
+101% +$6.38M 1.89% 18
2025
Q2 		$6.27M Sell
35,619
-63,053
-64% -$9.49M 0.91% 28
2025
Q1 		$13.3M Buy
98,672
+54,379
+123% +$7.16M 2.37% 14
2024
Q4 		$5.59M Sell
44,293
-1,337
-3% -$199K 1% 30
2024
Q3 		$7.58M Sell
45,630
-20,929
-31% -$3.17M 1.34% 31
2024
Q2 		$8.85M Buy
66,559
+48,977
+279% +$5.9M 1.54% 24
2024
Q1 		$1.85M Buy
17,582
+194
+1% +$17.4K 0.35% 42
2023
Q4 		$1.31M Buy
17,388
+3,626
+26% +$230K 0.27% 48
2023
Q3 		$907K Sell
13,762
-969
-7% -$72.4K 0.17% 47
2023
Q2 		$1.2M Sell
14,731
-28,273
-66% -$2.01M 0.21% 48
2023
Q1 		$2.56M Buy
+43,004
New +$2.39M 0.45% 44
2014
Q4 		– Sell
-1,332,633
Closed -$79.1M – 51
2014
Q3 		$79.1M Buy
+1,332,633
New +$74.4M 2.74% 17

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Sirios Capital Management's THC Position: Q2 2026 in Review

Sirios Capital Management reduced its Tenet Healthcare (THC) stake by 42% in Q2 2026, selling an estimated $2.92M and leaving 21,739 shares worth $4.07M. The position accounts for 0.49% of the portfolio, ranked #47.

Sirios Capital Management first reported a position in THC in Q3 2014 and has held it in 15 quarters since. The position peaked at $79.1M in Q3 2014. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Sirios Capital Management held 21,739 shares of Tenet Healthcare worth $4.07M as of Q2 2026.
  • Sirios Capital Management sold 15,905 Tenet Healthcare shares in Q2 2026, an estimated $2.92M.
  • Tenet Healthcare made up 0.49% of Sirios Capital Management's portfolio in Q2 2026, its #47 holding.
  • Sirios Capital Management first reported a position in Tenet Healthcare in Q3 2014 and has held it in 15 quarters since.
  • Sirios Capital Management's Tenet Healthcare position peaked at $79.1M in Q3 2014.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Sirios Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.